Tailored chemo and transplants show promise for adult blood cancer
NCT ID NCT02881086
First seen Jan 05, 2026 · Last updated May 05, 2026 · Updated 15 times
Summary
This study tested a more intensive, personalized treatment plan for over 1,000 adults newly diagnosed with acute lymphoblastic leukemia or lymphoblastic lymphoma. The approach used pediatric-style chemotherapy, targeted drugs, and stem cell transplants based on each patient's risk level. The goal was to improve long-term survival while managing side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Frankfurt (Main)
Frankfurt am Main, 60590, Germany
Conditions
Explore the condition pages connected to this study.